Skip to content
Politically.com Search all
Menu

Proposed rule 2026-23351

Rulemaking To Provide That N-acetyl-L-cysteine Is Not Excluded From the Dietary Supplement Definition

The Food and Drug Administration (FDA or we) is proposing to issue a regulation finding that N-acetyl-L-cysteine (NAC) is not excluded from the dietary supplement definition in the Federal Food, Drug, and Cosmetic Act (FD&C Act). This action, if finalized, would allow products containing NAC to be lawfully marketed as dietary supplements, provided that such products are not otherwise in violation of the FD&C Act. We also propose to provide that the addition of NAC to a dietary supplement is not a prohibited act under section 301(ll) of the FD&C Act.

Source: FederalRegister.gov API v1Latest available (refresh delayed). Last successful refresh: 2026-11-21 04:49:02 UTC.

Source-supplied record

Document details

Document number
2026-23351
Published
Nov 17, 2026
Effective
Not supplied
Comments close
Jan 19, 2027 (open)
Federal Register citation
91 FR 73717

Docket identifiers

  • Docket No. FDA-2025-N-2699

CFR references

  • Title 21, part 190